Directors fees running at ~600k per annum, Bez paid ~65k plus consulting fees of ~25k and 1m options last financial yearSo I'm more interested in what value Bez added for MNS & it's shareholders.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025